Prenatal Genetic Diagnosis in Three Fetuses With Left Heart Hypoplasia (LHH) From Three Unrelated Families

Sukun Luo1, Luyi Chen2, Weizhong Wei3

  • 1Precision Medical Center, Tongji Medical College, Wuhan Children's Hospital (Wuhan Maternal and Child Healthcare Hospital), Huazhong University of Science and Technology, Wuhan, China.

Insights

Genetic factors contribute to left heart hypoplasia (LHH), a severe congenital heart defect (CHD). Next-generation sequencing identified new gene variations (WDFY3) and confirmed others (KMT2D, NOTCH1) in affected fetuses, aiding diagnosis.

Area of Science:

  • Genetics
  • Developmental Biology
  • Pediatric Cardiology

Background:

  • Congenital heart defects (CHDs) are the most common birth defects.
  • Left heart hypoplasia (LHH) is a severe CHD, causing over 20% of infant cardiac deaths.
  • The genetic underpinnings of LHH remain largely unknown.

Purpose of the Study:

  • To investigate the genetic causes of fetal left heart hypoplasia (LHH).
  • To identify novel genetic variants associated with severe congenital heart defects.
  • To evaluate the utility of advanced sequencing techniques for diagnosing fetal CHDs.

Main Methods:

  • Recruitment of three families with fetal LHH.
  • Whole exome sequencing (WES) and copy number variation sequencing (CNV-seq) on fetal DNA.
  • Analysis of de novo mutations and deletions in candidate genes.

Main Results:

  • Identified de novo pathogenic variants in KMT2D and WDFY3 via trio-WES.
  • Detected a 150 kb deletion encompassing NOTCH1 using CNV-seq.
  • WDFY3 is implicated in human CHD for the first time, alongside known genes KMT2D and NOTCH1.

Conclusions:

  • Genetic factors are significant risk factors for LHH development.
  • Next-generation sequencing is a powerful tool for genetic diagnosis and counseling in fetal CHDs.
  • Further research is needed to correlate fetal phenotypes with specific genotypes.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
119
Fetal Circulation01:14

Fetal Circulation

Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
1.8K
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
314
Development of the Heart01:27

Development of the Heart

The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart...
1.6K
Pedigree Analysis01:35

Pedigree Analysis

Overview
87.0K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.6K